| HMGB1 mediates endogenous TLR2 activation and brain tumor regression JF Curtin, N Liu, M Candolfi, W Xiong, H Assi, K Yagiz, MR Edwards, ... PLoS medicine 6 (1), e1000010, 2009 | 397 | 2009 |
| Gene therapy and targeted toxins for glioma M G Castro, M Candolfi, K M Kroeger, G D King, J F Curtin, K Yagiz, ... Current gene therapy 11 (3), 155-180, 2011 | 118 | 2011 |
| B cells are critical to T-cell—mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastoma M Candolfi, JF Curtin, K Yagiz, H Assi, MK Wibowo, GE Alzadeh, ... Neoplasia 13 (10), 947-IN23, 2011 | 116 | 2011 |
| Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicity M Candolfi, K Yagiz, D Foulad, GE Alzadeh, M Tesarfreund, ... Clinical Cancer Research 15 (13), 4401-4414, 2009 | 113 | 2009 |
| Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics M Candolfi, W Xiong, K Yagiz, C Liu, A Muhammad, M Puntel, D Foulad, ... Proceedings of the National Academy of Sciences 107 (46), 20021-20026, 2010 | 109 | 2010 |
| Antiglioma immunological memory in response to conditional cytotoxic/immune-stimulatory gene therapy: humoral and cellular immunity lead to tumor regression AKM Ghulam Muhammad, M Candolfi, GD King, K Yagiz, D Foulad, ... Clinical Cancer Research 15 (19), 6113-6127, 2009 | 84 | 2009 |
| Gene therapy and virotherapy: novel therapeutic approaches for brain tumors KM Kroeger, AKMG Muhammad, GJ Baker, H Assi, MK Wibowo, W Xiong, ... Discovery medicine 10 (53), 293, 2010 | 73 | 2010 |
| Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile … FK Collak, K Yagiz, DJ Luthringer, B Erkaya, B Cinar Journal of Biological Chemistry 287 (28), 23698-23709, 2012 | 62 | 2012 |
| Gene therapy for brain cancer: combination therapies provide enhanced efficacy and safety M Candolfi, KM Kroeger, A Muhammad, K Yagiz, C Farrokhi, RN Pechnick, ... Current gene therapy 9 (5), 409-421, 2009 | 59 | 2009 |
| Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics M Candolfi, GD King, K Yagiz, JF Curtin, Y Mineharu, AKMG Muhammad, ... Neoplasia 14 (8), 757-IN26, 2012 | 52 | 2012 |
| STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer SK Mohanty, K Yagiz, D Pradhan, DJ Luthringer, MB Amin, S Alkan, ... Oncotarget 8 (49), 85997, 2017 | 48 | 2017 |
| Protective role of osteopontin in endodontic infection SR Rittling, C Zetterberg, K Yagiz, S Skinner, N Suzuki, A Fujimura, ... Immunology 129 (1), 105-114, 2010 | 47 | 2010 |
| Study of the efficacy, biodistribution, and safety profile of therapeutic gutless adenovirus vectors as a prelude to a phase I clinical trial for glioblastoma AKMG Muhammad, M Puntel, M Candolfi, A Salem, K Yagiz, C Farrokhi, ... Clinical Pharmacology & Therapeutics 88 (2), 204-213, 2010 | 45 | 2010 |
| Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model Y Mineharu, AKMG Muhammad, K Yagiz, M Candolfi, KM Kroeger, ... Neurotherapeutics 9 (4), 827-843, 2012 | 44 | 2012 |
| A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of … M Puntel, A Muhammad, M Candolfi, A Salem, K Yagiz, C Farrokhi, ... Journal of virology 84 (12), 6007-6017, 2010 | 44 | 2010 |
| Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models M Candolfi, K Yagiz, M Wibowo, GE Ahlzadeh, M Puntel, H Ghiasi, ... Clinical cancer research 20 (6), 1555-1565, 2014 | 40 | 2014 |
| Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial W Xiong, M Candolfi, C Liu, AKMG Muhammad, K Yagiz, M Puntel, ... PLoS One 5 (6), e11074, 2010 | 37 | 2010 |
| A retroviral replicating vector encoding cytosine deaminase and 5-FC induces immune memory in metastatic colorectal cancer models K Yagiz, ME Rodriguez-Aguirre, FL Espinoza, TT Montellano, D Mendoza, ... Molecular Therapy-Oncolytics 8, 14-26, 2018 | 34 | 2018 |
| Mapping the STK4/Hippo signaling network in prostate cancer cell D Ready, K Yagiz, P Amin, Y Yildiz, V Funari, S Bozdag, B Cinar PLoS One 12 (9), e0184590, 2017 | 30 | 2017 |
| Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation K Yagiz, SR Rittling Experimental cell research 315 (14), 2442-2452, 2009 | 27 | 2009 |
